Review Article
Sestrins at the Interface of ROS Control and Autophagy Regulation in Health and Disease
Table 1
Some examples of the cytoprotective effect by SESNs.
| Entry | Drugs or toxic substances | Cell lines | Tissue type/model organism | Effect on SESNs | Molecular mechanisms | Biological effect | Refs |
| 1 | Amyloid β-peptide | Primary rat cortical neurons | Transgenic mice | SESN2 ↑ | LC3B-II ↑ | Protective autophagy, prevention of neuronal cell death, protection against Alzheimer’s disease | [41] | 2 | Sevoflurane | M17 | Neuroblastoma | SESN2 ↑ | p53-dependent mechanism | Prevention of neuroapoptosis and ROS | [88] | 3 | 1-Methyl-4-phenylpyridinium | SH-SY5Y | Neuroblastoma | SESN2 ↑ | p53-dependent mechanism | Protection against oxidative stress, mitochondrial dysfunction, apoptosis, and cell death and protection against Parkinson’s disease | [92] | 4 | Chromium IV | Neuronal cells | Drosophila melanogaster larvae | dSESN ↑ | ATG-8 ↑, p-JNK, p-Akt, p-FoxO, cleaved caspase-3 ↓, TOR/p-S6k ↓ | Protection against oxidative stress, apoptosis, and neuronal cell death and protective autophagy | [97] | 5 | Angiotensin II | HUVECs | Endothelial | SESN2 ↑ | JNK/c-Jun pathway ↑ | Protection against cardiotoxicity of angiotensin II | [102] | 6 | Acetaminophen | Liver cell | Mice | SESN2 ↑ | JNK, ERK pathway ↓, p38 ↓ | Inhibition of oxidative stress, proinflammatory signalling, protection against liver toxicity | [103] |
|
|